Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
190.00    0.00 (0.00%)
Bid:
185.00
Ask:
195.00
Spread: 10.00 (5.405%)
Market Cap: £98.47m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

Trading Update

24 Jul 2023 07:00

RNS Number : 8395G
Somero Enterprises Inc.
24 July 2023
 

24 July 2023

Somero Enterprises, Inc.

("Somero", "the Company" or "the Group")

 

Trading Update

Somero® provides an update on trading for the six months to 30 June 2023 ahead of its interim results announcement, scheduled for release on 31 August 2023.

With non-residential construction and underlying market conditions remaining healthy across the Company's major markets and following a solid June, trading for H1 2023 ended at the high end of the guidance range set forth in the 20 June 2023 trading update.

 

As expected, trading in North America was the driver for the overall decline compared to H1 2022, due to the factors previously reported in the 20 June 2023 trading update, while H1 2023 trading in Europe and Australia reflected the positive momentum carried forward from H2 2022 with both regions reporting improvement over the comparable H1 2022 result. Performance in the European and Australian markets, supported by healthy market activity, has been driven by strategic investments in both regions and traction with acquiring new customer relationships and with increased market penetration of our broader product offering. Territories comprising our Rest of World regions contributed positively to H1 2023 trading on a combined basis as expected, driven in part by Latin America and the Middle East that both reported increased revenues compared to H1 2022.

 

Also as indicated in our 20 June 2023 trading update, the Company anticipates improvement in H2 2023 trading in North America compared to H1 2023 driven by increased availability of the S-22EZ, supported by direct feedback from customers indicating healthy non-residential construction activity across a wide range of project types that translates to extended project backlogs. The Company also anticipates healthy contributions to H2 2023 trading from Europe and Australia, and H2 2023 trading comparable to H1 2023 in the Rest of World territories. 

 

As such, the Board remains confident that 2023 results will fall in line with market expectations with revenues of approximately US$ 120m, EBITDA of approximately US$ 36m, and year-end cash of approximately US$ 32m.

 

 

Enquiries:

 

 

 

Somero Enterprises, Inc.

www.somero.com

Jack Cooney, CEO

+1 239 210 6500

John Yuncza, President

 

Vincenzo LiCausi, CFO

 

Howard Hohmann, EVP Sales

 

 

 

finnCap Ltd (NOMAD and Broker)

+44 (0)20 7220 0500

Matt Goode/Seamus Fricker/Fergus Sullivan (Corporate Finance)

 

Tim Redfern/Harriet Ward (ECM)

 

 

 

Alma PR (Financial PR Advisor)

somero@almapr.co.uk

David Ison

+44 (0)20 3405 0205

Rebecca Sanders-Hewett

Pippa Crabtree

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKDBBDBKDPOB
Date   Source Headline
6th May 20257:00 amRNSRestricted Stock Units, Director/PDMR Shareholding
1st May 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
1st May 20257:00 amRNSAnnual Report and Notice of AGM
30th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Apr 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20257:00 amRNSTrading Update
22nd Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20257:00 amRNSAppointment of New Chairman
11th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Apr 20254:35 pmRNSHolding(s) in Company
1st Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Mar 20257:00 amRNSAppointment of New CEO
20th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Mar 20257:00 amRNSRSUs & Director/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Mar 20257:00 amRNSFinal Results
7th Mar 20252:35 pmRNSHolding(s) in Company
6th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Feb 20257:00 amRNSHolding(s) in Company
27th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Feb 20257:00 amRNSNotice of Investor Presentation
3rd Feb 20256:10 pmRNSHolding(s) in Company
30th Jan 20257:00 amRNSTrading Update
20th Dec 20247:00 amRNSDirectorate Changes
17th Dec 20245:04 pmRNSHolding(s) in Company
5th Dec 20245:02 pmRNSHolding(s) in Company
5th Dec 20244:41 pmRNSHolding(s) in Company
4th Dec 20244:29 pmRNSHolding(s) in Company
26th Nov 20244:47 pmRNSHolding(s) in Company
21st Nov 20249:41 amRNSHolding(s) in Company
19th Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Nov 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Aug 20247:00 amRNSInterim Results
20th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Aug 20247:00 amRNSNotice of Investor Presentation
31st Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jul 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.